[New prospects in the treatment of urinary tract infections with modified-release ciprofloxacin].
Trinchieri
Alberto
A
Struttura Complessa di Urologia, Ospedale A. Manzoni, Lecco, Italy. a.trinchieri@ospedale.leco.it
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D017326:Clinical Trials, Phase III as Topic; D003692:Delayed-Action Preparations; D004347:Drug Interactions; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D013210:Staphylococcus / Q000187:drug effects; D011795:Surveys and Questionnaires; D013997:Time Factors; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000652:urine
D003692:Delayed-Action Preparations; D002939:Ciprofloxacin